RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.
The Ewings Sarcoma Oncoprotein (EWS) interacts with several components of the mammalian transcriptional and pre-mRNA splicing machinery and is also found in the cytoplasm and even on the cell surface. The apparently diverse cellular functions of EWS are, however, not well characterized. EWS harbours a potent N-terminal transcriptional activation domain (the EAD) that is revealed in the context of oncogenic EWS-fusion proteins (EFPs) and a C-terminal RNA-binding domain (RBD) that recruits pre-mRNA splicing factors and may couple transcription and splicing. In contrast to EFPs, the presumed transcriptional role of normal EWS remains enigmatic. Here, we report that multiple RGG-boxes within the RBD are necessary and sufficient for cis-repression of the EAD and that RGG-boxes can also repress in-trans, within dimeric partners. Lys can functionally substitute for Arg, indicating that the basic nature of the Arg side chain is the critical determinant of RGG-box-mediated repression. In addition to the EAD, RGG-boxes can repress a broad range of activation domains (including those of VP16, E1a and CREB), but repression can be alleviated by the simultaneous presence of more than one activation domain. We therefore propose that a key function of RGG boxes within native EWS is to restrict promiscuous activation by the EAD while still allowing EWS to enter functional transcription complexes and participate in other transactions involving pre-mRNAs.
Alex
Deepa
D
Department of Biology, Hong Kong University of Science & Technology Clear Water Bay, Kowloon Hong Kong, SAR, China.
Lee
Kevin A W
KA
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D002460:Cell Line; D004252:DNA Mutational Analysis; D019281:Dimerization; D006801:Humans; D008969:Molecular Sequence Data; D017434:Protein Structure, Tertiary; D034802:RNA-Binding Protein EWS / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D015534:Trans-Activators / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D015533:Transcriptional Activation
D034802:RNA-Binding Protein EWS; D012097:Repressor Proteins; D015534:Trans-Activators
Nucleic Acids Res. 1999 Feb 1;27(3):817-21
9889278
Cell. 1999 Apr 2;97(1):5-8
10199396
Cell. 1999 Apr 2;97(1):17-27
10199399
Mol Cancer Res. 2002 Nov;1(1):48-55
12496368
J Biol Chem. 2003 Feb 14;278(7):5427-32
12459554
Chromosoma. 2003 Apr;111(7):461-9
12707784
Curr Biol. 1999 May 6;9(9):485-8
10322114
Curr Opin Oncol. 1999 Jul;11(4):275-84
10416880
Mol Cell Biol. 1999 Oct;19(10):6833-44
10490622
Genes Dev. 2003 Aug 1;17(15):1909-20
12897056
Brain Res Mol Brain Res. 2003 Nov 6;119(1):37-49
14597228
Genomics. 2004 Jan;83(1):130-9
14667816
FEBS Lett. 2004 Apr 23;564(1-2):188-98
15094065
J Virol. 1984 Nov;52(2):483-91
6208378
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6682-6
2875459
Oncogene. 1999 Dec 23;18(56):8000-10
10637511
J Biol Chem. 2000 Aug 11;275(32):24865-71
10827180
J Biol Chem. 2000 Jul 28;275(30):23053-8
10767297
Physiol Genomics. 1999 Nov 11;1(3):127-38
11015571
J Biol Chem. 2000 Dec 1;275(48):37612-8
10982800
J Biol Chem. 2001 Mar 2;276(9):6807-16
11098054
Cancer Res. 2001 Mar 15;61(6):2690-5
11289149
J Biol Chem. 2001 Apr 20;276(16):13395-401
11278855
Oncogene. 2001 Mar 22;20(12):1519-24
11313895
Oncogene. 2001 Mar 29;20(14):1756-64
11313922
Cancer Res. 2001 May 1;61(9):3586-90
11325824
J Biol Chem. 2001 Jun 1;276(22):18681-7
11278906
J Biol Chem. 2001 Jun 22;276(25):22317-22
11301318
Oncogene. 2001 Jul 12;20(31):4161-8
11464282
Oncogene. 2001 Sep 10;20(40):5747-54
11607824
Oncogene. 2001 Oct 11;20(46):6653-9
11709699
J Biol Chem. 2002 Jan 4;277(1):535-43
11673470
Mol Cell Biol. 2002 May;22(9):2918-27
11940650
Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):224-8
1898773
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2723-6
1557378
EMBO J. 1992 Jul;11(7):2655-64
1628625
J Virol. 1992 Aug;66(8):4803-13
1321270
New Biol. 1992 May;4(5):421-9
1381215
EMBO J. 1992 Dec;11(13):5005-12
1464322
Genes Dev. 1993 Feb;7(2):173-9
8436289
Annu Rev Biochem. 1993;62:289-321
8352591
Biochim Biophys Acta. 1993 Sep 23;1174(3):221-33
8373801
Nat Genet. 1993 Aug;4(4):341-5
8401579
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9046-50
8105470
Science. 1994 Jul 29;265(5172):615-21
8036511
Oncogene. 1994 Oct;9(10):3087-97
8084618
Mol Cell Biol. 1994 Nov;14(11):7204-10
7935435
Oncogene. 1994 Dec;9(12):3717-29
7970732
J Biol Chem. 1994 Dec 9;269(49):31124-8
7983053
Oncogene. 1995 May 4;10(9):1749-56
7753552
Mol Cell Biol. 1995 Aug;15(8):4562-71
7623847
Nucleic Acids Res. 1995 Jul 11;23(13):2389-95
7630716
Oncogene. 1996 Jan 4;12(1):159-67
8552387
J Biol Chem. 1996 Feb 16;271(7):3420-7
8631943
EMBO J. 1996 Sep 16;15(18):5022-31
8890175
Biochemistry. 1997 Apr 29;36(17):5185-92
9136880
J Cell Sci. 1997 Aug;110 ( Pt 15):1741-50
9264461
J Biol Chem. 1997 Oct 24;272(43):27369-77
9341188
Mol Endocrinol. 1998 Jan;12(1):4-18
9440806
Mol Cell Biol. 1998 Mar;18(3):1489-97
9488465
J Biol Chem. 1998 Feb 27;273(9):4838-42
9478924
Oncogene. 1998 Mar 26;16(12):1625-31
9569031
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6699-704
9618475
J Biol Chem. 1998 Jun 19;273(25):15521-7
9624140
Oncogene. 1998 Aug 6;17(5):603-10
9704926
J Biol Chem. 1998 Oct 23;273(43):27761-4
9774382
J Biol Chem. 1998 Oct 30;273(44):29224-9
9786934